Xintela AB (XINT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.242x

Based on the latest financial reports, Xintela AB (XINT) has a cash flow conversion efficiency ratio of 0.242x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.74 Million ≈ $-724.90K USD) by net assets (Skr-27.88 Million ≈ $-3.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Xintela AB - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Xintela AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Xintela AB (XINT) financial obligations for a breakdown of total debt and financial obligations.

Xintela AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xintela AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
RNI Negócios Imobiliários S.A SA:RDNI3	-0.026x
Korean Air Lines Co Ltd KO:003495	0.039x
Apimeds Pharmaceuticals US, Inc. NYSE MKT:APUS	-0.212x
Lead Real Estate Co., Ltd American Depositary Shares NASDAQ:LRE	94.590x
Millcon Steel Public Company Limited BK:MILL	-0.289x
Bull Will Co Ltd TWO:6259	0.031x
Tips Films Limited NSE:TIPSFILMS	0.011x
Flexion Mobile PLC ST:FLEXM	0.022x

Annual Cash Flow Conversion Efficiency for Xintela AB (2013–2024)

The table below shows the annual cash flow conversion efficiency of Xintela AB from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Xintela AB (XINT) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr-5.95 Million ≈ $-640.32K	Skr-40.70 Million ≈ $-4.38 Million	6.841x	+156.41%
2023-12-31	Skr4.38 Million ≈ $471.36K	Skr-53.12 Million ≈ $-5.72 Million	-12.127x	-77.41%
2022-12-31	Skr5.78 Million ≈ $621.70K	Skr-39.49 Million ≈ $-4.25 Million	-6.836x	+37.10%
2021-12-31	Skr3.95 Million ≈ $424.76K	Skr-42.89 Million ≈ $-4.62 Million	-10.867x	-1306.49%
2020-12-31	Skr27.61 Million ≈ $2.97 Million	Skr-21.33 Million ≈ $-2.30 Million	-0.773x	+76.68%
2019-12-31	Skr9.32 Million ≈ $1.00 Million	Skr-30.89 Million ≈ $-3.32 Million	-3.313x	-377.25%
2018-12-31	Skr44.95 Million ≈ $4.84 Million	Skr-31.20 Million ≈ $-3.36 Million	-0.694x	+11.03%
2017-12-31	Skr18.41 Million ≈ $1.98 Million	Skr-14.37 Million ≈ $-1.55 Million	-0.780x	+5.90%
2016-12-31	Skr20.98 Million ≈ $2.26 Million	Skr-17.40 Million ≈ $-1.87 Million	-0.829x	+35.11%
2015-12-31	Skr7.46 Million ≈ $802.92K	Skr-9.54 Million ≈ $-1.03 Million	-1.278x	-193.91%
2014-12-31	Skr9.54 Million ≈ $1.03 Million	Skr-4.15 Million ≈ $-446.50K	-0.435x	+26.64%
2013-12-31	Skr5.08 Million ≈ $546.88K	Skr-3.01 Million ≈ $-324.14K	-0.593x	--

About Xintela AB

ST:XINT Sweden Biotechnology

Market Cap

$17.71 Million

Skr164.59 Million SEK

Market Cap Rank

#25404 Global

#522 in Sweden

Share Price

Skr0.23

Change (1 day)

-1.68%

52-Week Range

Skr0.21 - Skr0.50

All Time High

Skr8.60